{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:32:13Z","timestamp":1784179933611,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T00:00:00Z","timestamp":1777161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005104","name":"Australian Institute of Health and Welfare, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128644","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:17:28Z","timestamp":1777735048000},"page":"128644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis"],"prefix":"10.1016","volume":"83","author":[{"given":"Kishor K.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophy T.F.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen L.","family":"Nazareno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Newall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2026.128644_bb0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jhin.2018.03.034","article-title":"Respiratory syncytial virus burden among adults during flu season: an underestimated pathology","volume":"100","author":"Kestler","year":"2018","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128644_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2016.02.025","article-title":"Morbidity and mortality among patients with respiratory syncytial virus infection: a 2-year retrospective review","volume":"85","author":"Anderson","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128644_bb0015","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/irv.13003","article-title":"Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009-2017","volume":"16","author":"Nazareno","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128644_bb0020","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae384","article-title":"Neighborhood-level burden of social risk factors on respiratory syncytial virus hospitalization in Ontario, Canada, 2016\u20132019","volume":"11","author":"Chen","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128644_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41479-022-00098-x","article-title":"Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups","volume":"14","author":"Zheng","year":"2022","journal-title":"Pneumonia"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128644_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae184","article-title":"Respiratory syncytial virus hospitalizations associated with social vulnerability by census tract: an opportunity for intervention?","volume":"11","author":"Thomas","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128644_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13346","article-title":"Comparison of the burden and temporal pattern of hospitalisations associated with respiratory syncytial virus (RSV) before and after COVID-19 in New Zealand","volume":"18","author":"Turner","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128644_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-05989-w","article-title":"Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015\u20132017","volume":"21","author":"Holmen","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128644_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234235","article-title":"The health and economic burden of respiratory syncytial virus associated hospitalizations in adults","volume":"15","author":"Prasad","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128644_bb0050","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12879-016-1820-8","article-title":"Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake","volume":"16","author":"Dyda","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128644_bb0055","article-title":"Incomplete vaccination and its predictors among children in Ethiopia: a systematic review and meta-analysis","volume":"7","author":"Desalew","year":"2020","journal-title":"Glob Pediatr Health"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128644_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234702","article-title":"Seasonal influenza vaccination in older people: a systematic review and meta-analysis of the determining factors","volume":"15","author":"Okoli","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128644_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294688","article-title":"Socioeconomic inequalities in vaccine uptake: A global umbrella review","volume":"18","author":"Sacre","year":"2023","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128644_bb0070","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.vaccine.2020.03.036","article-title":"Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program","volume":"38","author":"Lin","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128644_bb0075","series-title":"Socioeconomic determinants of vaccine uptake: July 2021 to January 2022","author":"Biddle","year":"2022"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128644_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0272989X15583266","article-title":"Distributional cost-effectiveness analysis: a tutorial","volume":"36","author":"Asaria","year":"2016","journal-title":"Med Decis Mak"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128644_bb0085","first-page":"1","article-title":"Health and equity in New South Wales","volume":"15","author":"Harris","year":"2004","journal-title":"New South Wales Public Health Bull Suppl Series"},{"key":"10.1016\/j.vaccine.2026.128644_bb0090","author":"Government of Western Australia Department of Health"},{"key":"10.1016\/j.vaccine.2026.128644_bb0095","unstructured":"Government of Victoria Department of Health. Victorian public health and wellbeing plan 2023-27 [cited 20 August 2025]. Available from: https:\/\/www.health.vic.gov.au\/victorian-public-health-and-wellbeing-plan-2023-27."},{"key":"10.1016\/j.vaccine.2026.128644_bb0100","author":"Australian Government Department of Health, Disability and Ageing"},{"key":"10.1016\/j.vaccine.2026.128644_bb0105","author":"Therapeutic Goods Administration"},{"key":"10.1016\/j.vaccine.2026.128644_bb0110","author":"Therapeutic Goods Administration"},{"key":"10.1016\/j.vaccine.2026.128644_bb0115","doi-asserted-by":"crossref","first-page":"128591","DOI":"10.1016\/j.vaccine.2026.128591","article-title":"Estimating the cost-effectiveness of respiratory syncytial virus (RSV) vaccination program for older Australian adults","volume":"82","author":"Paul","year":"2026","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128644_bb0120","author":"Australian Bureau of Statistics"},{"key":"10.1016\/j.vaccine.2026.128644_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2024.117495","article-title":"Aversion to income, ethnic, and geographic related health inequality: evidence from Australia","volume":"364","author":"Boujaoude","year":"2025","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2026.128644_bb0130","author":"Australian Bureau of Statistics"},{"key":"10.1016\/j.vaccine.2026.128644_bb0135","author":"Australian Bureau of Statistics"},{"key":"10.1016\/j.vaccine.2026.128644_bb0140","author":"The Pharmaceutical Benefits Scheme"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128644_bb0145","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02688-2020","article-title":"Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study","volume":"57","author":"Korsten","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2026.128644_bb0150","author":"Australian Institute of Health and Welfare"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128644_bb0155","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S2213-2600(25)00048-7","volume":"13","author":"Ison","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128644_bb0160","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1093\/cid\/ciaf061","article-title":"Efficacy, immunogenicity, and safety of the bivalent respiratory syncytial virus (RSV) prefusion F vaccine in older adults over 2 RSV seasons","volume":"81","author":"Walsh","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128644_bb0165","series-title":"Exploratory analysis of the first 2 years of adult vaccination data recorded on AIR","author":"Hull","year":"2019"},{"key":"10.1016\/j.vaccine.2026.128644_bb0170","author":"Australian Government Department of Health, Disability and Aging"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128644_bb0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40273-017-0585-2","article-title":"Estimating the reference incremental cost-effectiveness ratio for the Australian health system","volume":"36","author":"Edney","year":"2018","journal-title":"PharmacoEconomics"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128644_bb0180","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hec.3058","article-title":"Distributional cost-effectiveness analysis of health care programmes \u2013 a methodological case study of the UK bowel cancer screening programme","volume":"24","author":"Asaria","year":"2015","journal-title":"Health Econ"},{"key":"10.1016\/j.vaccine.2026.128644_bb0185","author":"National Institute for Health and Care Excellence (NICE)"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128644_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/0272989X20904360","article-title":"Estimating social variation in the health effects of changes in health care expenditure","volume":"40","author":"Love-Koh","year":"2020","journal-title":"Med Decis Mak"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128644_bb0195","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/hec.3430","article-title":"Eliciting the level of health inequality aversion in England","volume":"26","author":"Robson","year":"2017","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128644_bb0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamainternmed.2025.6355","article-title":"Durability of respiratory syncytial virus vaccine effectiveness among US veterans","volume":"186","author":"Bajema","year":"2026","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.vaccine.2026.128644_bb0205","author":"Australian Government Services Australia"},{"key":"10.1016\/j.vaccine.2026.128644_bb0210","series-title":"Listings on the PBS for Aboriginal and Torres Strait Islander people","author":"Department of Health, Disability and Ageing","year":"2025"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:17:16Z","timestamp":1783041436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26004524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"alternative-id":["S0264410X26004524"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128644","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory syncytial virus (RSV) vaccination program for older Australians reduces health inequalities: a distributional cost-effectiveness analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128644"}}